PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
July 8, 2024Frontiers in OncologyOpen Access

Camrelizumab combined with anlotinib as second-line therapy for metastatic or recurrent small cell lung cancer: a retrospective cohort study

View Full Paper
Ask AI
Bookmark
Share

Authors

SSShujing ShenXLXingya LiSGSanxing Guo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Shen et al. (2024) studied this question.

synapsesocial.com/papers/68e60f70b6db6435875a2e56https://doi.org/10.3389/fonc.2024.1391828
View Full Paper
Ask AI
Bookmark
Share